CD10/Neprilysin Antibody (Rabbit mAb) [J20L24]

CatNo: F5284

    Application: Reactivity:
    • Lane 1: Raji, Lane 2: Ramos, Lane 3: Mouse lung, Lane 4: Rat lung
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000-1:5000
    1:30
    1:500
    1:500
    Application
    WB, IP, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    86 kDa 100 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Rat lung tissue; Human placenta tissue; Rat kidney tissue; Mouse kidney tissue; Human diffuse large B-cell lymphoma tissue; Human tonsil tissue; Human kidney tissue; Mouse lung tissue; HAP1 cells; Raji cells; Ramos cells
    ネガティブコントロール HT-29 cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Add protein loading buffer to the 20 μL sample, and keep it on ice for immediate use; or determine the optimal denaturation conditions by boiling the sample at a temperature gradient (e.g., 37°C, 50°C, 70°C, 90°C, and 100°C). Cool the sample on ice and centrifuge for 5 min.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    CD10/Neprilysin Antibody (Rabbit mAb) [J20L24] detects endogenous levels of total CD10/Neprilysin protein.
    タンパク質の局在
    細胞膜、細胞内膜系
    Uniprot ID
    P08473
    Clone
    J20L24
    Synonym(s)
    CD10, EPN, MME, Neprilysin, Atriopeptidase, Common acute lymphocytic leukemia antigen, Enkephalinase, Neutral endopeptidase 24.11, Skin fibroblast elastase, CALLA, NEP, Neutral endopeptidase, SFE
    Background
    CD10, also known as neprilysin, neutral endopeptidase, membrane metalloendopeptidase, and CALLA, belongs to the M13 family of zinc-dependent metalloendopeptidases and is synthesized as a type II transmembrane protein anchored at the plasma membrane, with its catalytic ectodomain oriented extracellularly where it degrades small secreted peptides directly at the cell surface. The enzyme carries relatively broad substrate specificity but shows a defined cleavage preference, hydrolyzing peptide bonds specifically on the amino-terminal side of hydrophobic residues, a mechanistic rule that governs which bioactive peptides neprilysin processes and explains its activity across chemically diverse substrates including enkephalins, atrial natriuretic peptide, bradykinin, and the amyloid-beta peptide. Among these substrates, amyloid-beta has received particular attention because neprilysin functions as one of the principal enzymes clearing this peptide in brain tissue, and an inverse relationship exists between neprilysin levels and both amyloid-beta peptide concentration and amyloid plaque burden in human brain tissue, with neprilysin levels additionally declining with normal aging in temporal and frontal cortex, a decline proposed to contribute to elevated amyloid-beta accumulation over time. Kinetic characterization of the wild-type enzyme acting on amyloid-beta 1-40 establishes defined Michaelis-Menten parameters for this substrate, and protein engineering of the soluble neprilysin ectodomain to improve catalytic efficiency toward amyloid-beta produces a variant with roughly twentyfold greater catalytic efficiency on amyloid-beta 1-40 compared to the wild-type enzyme, directly demonstrating that neprilysin's substrate-binding cleft can be structurally modified to favor amyloid-beta degradation over its many other physiological substrates, a property directly relevant to therapeutic engineering given that neprilysin's native broad specificity limits its use as an Alzheimer's disease treatment without such modification. In neurons, neprilysin expression and activity are regulated by nicastrin, a component of the gamma-secretase complex that also performs the proteolytic step converting amyloid precursor protein into amyloid-beta, linking the enzyme responsible for amyloid-beta generation to a regulatory input controlling the enzyme responsible for its clearance. Beyond its role in the central nervous system, CD10 is broadly expressed across kidney, lung, neutrophils, and lymphoid tissue, where it terminates signaling by inactivating natriuretic and kinin peptides relevant to blood pressure and fluid homeostasis, and CD10 serves as a clinically established immunohistochemical marker in lymphoid malignancies, including certain lymphomas and B-lymphoblastic leukemia, reflecting its differential expression across stages of lymphocyte development.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください